Boehringer Ingelheim's top self-medication drugs revenues 2008-2016

This statistic shows the revenues of pharmaceutical company Boehringer Ingelheim's top self-medication drugs from 2008 to 2016. In 2008, the company achieved net sales of some 99 million euros with the product Buscopan. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany.

Revenues of Boehringer Ingelheim's top self-medication products 2008 to 2016

DulcolaxBuscopanPharmatonMucosolvan
-----
-----
-----
-----
-----
-----
-----
-----
-----
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2017

Region

Worldwide

Survey time period

2008 to 2016

Supplementary notes

Figures prior to 2016 were taken from previous annual reports.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.